id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-1413	Otieno, Collins O.; Mataka, Anafi; Loembe, Marguerite Massinga; Ondoa, Pascale	Maintaining routine HIV and tuberculosis testing services in sub-Saharan African countries in the context of COVID-19: Lessons learnt and opportunities for improvement	2021		.htm	text/html	2960	134	37	A World Health Organization survey of essential services revealed that HIV testing (n = 38) and viral load monitoring (n = 23) were the two most frequently interrupted testing services in the 61 countries that responded.11 It is important to note that laboratory testing is key to identifying disease cases, breaking transmission chains and monitoring patients on treatment. At least three COVID-19 molecular diagnostic assays listed under the emergency use authorisations of the United States Food and Drug Administration or the World Health Organization can be used on platforms commonly available within the HIV and tuberculosis programmes – the Abbott m2000 RealTime System, Cepheid’s GeneXpert® system, and the Roche Cobas 6800/8800 system.3 Although COVID-19 testing volumes in most African countries remain below or at the lower threshold required for relaxing the containment measures (10–30 tests per confirmed case),4 have we gone a step too far in refocusing most of the laboratory capacity to COVID-19 testing?	cache/ajlm-1413.htm	txt/ajlm-1413.txt